“Extensive and frequent laboratory examination in transgender adolescents may be unnecessary.”
What an interesting phrase. That is a highly unusual thing to suggest in a situation where children are being given drugs with so little data, for a couple of reasons.
Firstly, if it’s your drug, you WANT that data. It’s valuable - you want to see what it does in a population. Secondly, for legal reasons - you want the data because you should be looking for and open to post marketing findings (ie stuff that wasn’t found in the limited population of a trial) because if it’s known about and you don’t act on it your arse is getting sued
Thirdly, and most importantly, for SAFETY. You are giving a drug off label to a paediatric population. You need to be watching it like a hawk.
This is all just so wrong. It’s against everything that’s been laid down ovEr the years after the neuremberg trials - rules designed to stop unethical use of humans as Guinea pigs.
There is something very wrong and very sinister about all this.
‘Sue’ has done a sterling job with this (did she (?) write the article about funding as well? I am very impressed.